Patent 7494658 was granted and assigned to MediGene on February, 2009 by the United States Patent and Trademark Office.
Vaccine formulations comprising, viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.